← All drugs Report issue

bcd-281

mAbexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

B-lymphocyte antigen CD20INHIBITOR
MS4A1 inhibitor
- B-lymphocyte antigen CD20 (MS4A1) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No